Bio Basic is pleased to announce it has acquired the Molecular Biology portfolio of Feldan.
Bio Basic will begin managing the portfolio (which includes PCR Enzymes, DNA Prep Kits, Real Time PCR) effective immediately, and will continue to be the exclusive supplier of Feldan Molecular Biology products into the future.
Feldan is a Quebec based biotechnology company engaged in the discovery, development, manufacturing and marketing of Research, Therapeutic and Industrial protein products and services. The company's innovation pipeline currently focuses on research areas that target treatment of serious illness in areas such as oncology, immunology, neuroscience, inflammation and stem cell therapy.
Bio Basic has teamed up with Feldan to diversify its molecular biology catalogue. In addition to offering high quality PCR products and enzymes, Feldan offers the best Midi- and Maxi-preps on the market.
“We at Bio Basic are pleased to expand our portfolio. After twenty years in the biotechnology business, we have developed a reputation for quality products and services and are excited for the opportunity to grow our business in such an important market,” says Jamie Hughes, Director of Sales and Marketing.